APLN and type 2 diabetes mellitus: Recent reports in patients with type 2 diabetes mellitus manifested the expression of tight junction markers, including GJA1, was significantly suppressed by hyper-activating Apelin (APLN) peptide and downregulated in diabetic testis (55).